Prosecution Insights
Last updated: August 18, 2026

Examiner: ROONEY, NORA MAUREEN

Tech Center 1600 • Art Units: 1641 1644

This examiner grants 60% of resolved cases

Performance Statistics

60.2%
Allow Rate
At TC average
775
Total Applications
+23.8%
Interview Lift
1271
Avg Prosecution Days
Based on 746 resolved cases, 2023–2026

Rejection Statute Breakdown

7.9%
§101 Eligibility
20.6%
§102 Novelty
21.7%
§103 Obviousness
35.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18311075 SONOGENETIC MODULATION OF CELLS EXPRESSING BACTERIALLY-DERIVED MECHANOSENSITIVE PROTEINS Non-Final OA The Regents of the University of California
18016243 TARGET-RECOGNITION OF ANTIGEN-MHC COMPLEX REPORTER (TRACER) PLATFORM Final Rejection The Board of Trustees of the Leland Stanford Junior University
18669172 Anti-CTLA-4 Antibodies and Uses Thereof Non-Final OA Regeneron Pharmaceuticals, Inc.
18015684 COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY Non-Final OA THE JOHNS HOPKINS UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month